• Beginning with chronic pancreatitis, we are committed to advancing new therapies and accelerating a cure for debilitating and untreatable diseases—within ten years.


  • We envision a world where people afflicted with pancreatitis and other debilitating and untreatable diseases can count on life-saving treatments—instead of suffering in isolation without hope.

We serve the patients & communities affected by recurrent acute and chronic pancreatitis. Our impact extends to disease research and healthcare, applying innovative financing models to advance new therapies and cures.


Potential drug repurposing candidates identified
  • Defined strategy to cure chronic pancreatitis within 10 years with input from key opinion leaders (KOLs)
  • Organized & led patient panel at The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) meeting on expediting therapies for pancreatitis
  • Launched our patient education program, including webinars with over 5,500 views and blog posts with more than 10,000 page visits
  • Conducted the first chronic pancreatitis patient-needs survey and co-hosted a Patient-Focused Drug Development meeting for the FDA
  • Identified 60 potential drug repurposing candidates that have evidence of action on pancreatitis targets
  • Awarded Innovative Practices Award for Elsevier/Pistoia Alliance Datathon, an international data science competition that generated 300 drug repurposing candidates
  • Built a robust network of patients eager to participate in clinical trials